Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Z Weizer

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Urologic Oncology|January 9, 2010
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?Jay D Raman, Shahrokh F Shariat, Pierre I Karakiewicz, et al.
Urologic Oncology|February 4, 2012
Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic researchRobert S Svatek, Jonathan E Rosenberg, Matthew D Galsky, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Urologic Oncology|October 1, 2016
Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs)Scott R Hawken, Naveen K Krishnan, Sapan N Ambani, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
The American Journal of Surgical Pathology|January 21, 2015
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenomaAaron M Udager, Jincheng Pan, Martin J Magers, et al.
Cancer|January 31, 2014
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancerMichael Hu, Bruce L Jacobs, Jeffrey S Montgomery, et al.
Urology|March 8, 2017
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge CareTudor Borza, Bruce L Jacobs, Jeffrey S Montgomery, et al.
European Urology Focus|July 30, 2017
The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission IntervalNaveen Krishnan, Benjamin Li, Bruce L Jacobs, et al.
Urology|July 25, 2016
Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?Sapan N Ambani, Todd M Morgan, Jeffrey S Montgomery, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Urologic Oncology|January 9, 2010
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?Jay D Raman, Shahrokh F Shariat, Pierre I Karakiewicz, et al.
Urologic Oncology|February 4, 2012
Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic researchRobert S Svatek, Jonathan E Rosenberg, Matthew D Galsky, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Urologic Oncology|October 1, 2016
Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs)Scott R Hawken, Naveen K Krishnan, Sapan N Ambani, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
The American Journal of Surgical Pathology|January 21, 2015
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenomaAaron M Udager, Jincheng Pan, Martin J Magers, et al.
Cancer|January 31, 2014
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancerMichael Hu, Bruce L Jacobs, Jeffrey S Montgomery, et al.
Urology|March 8, 2017
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge CareTudor Borza, Bruce L Jacobs, Jeffrey S Montgomery, et al.
European Urology Focus|July 30, 2017
The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission IntervalNaveen Krishnan, Benjamin Li, Bruce L Jacobs, et al.
Urology|July 25, 2016
Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?Sapan N Ambani, Todd M Morgan, Jeffrey S Montgomery, et al.
Pageof 18